Key Segmentation:
By Type
-
Coronary DCB
-
Peripheral DCB
By End Use
-
Hospitals
-
Specialty Cardiac/Vascular Centers
-
Ambulatory Surgical Centers (ASCs)
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company's specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Type X End Use)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Boston Scientific, Medtronic, B. Braun, Concept Medical, Abbott, Philips, Teleflex, Translumina, MicroPort, Cardionovum, and iVascular.
Key opportunities include sirolimus-based coating innovation, emerging-market expansion, AI-assisted imaging integration, and growing demand for stent-free vascular interventions globally.
The market is driven by rising cardiovascular disease prevalence, increasing minimally invasive procedures, and growing preference for stent-free revascularization strategies worldwide.
The Peripheral DCB segment dominated the Drug-Coated Balloon Catheters Market, accounting for approximately 71.40% market share in 2025.
North America dominated the Drug-Coated Balloon Catheters Market in 2025, accounting for approximately 44.50% share, supported by advanced cardiovascular care infrastructure.
